11 min listen
ACCEL Lite: ESC Congress 2021 Late Breaker: EMPEROR-Preserved
FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ACCEL Lite: ESC Congress 2021 Late Breaker: EMPEROR-Preserved
FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ratings:
Length:
13 minutes
Released:
Sep 21, 2021
Format:
Podcast episode
Description
In this interview, Jeroen Bax, PhD, MD, FACC; Stefan Anker, MD, PhD; and Sherry-Ann Brown, MD, PhD, FACC, discuss the ESC Congress 2021 late breaker EMPEROR-Preserved, which evaluates the effect of empagliflozin for risk of cardiovascular death and hospitalisation for patients with heart failure and a preserved fraction with and without diabetes. Like what you hear? Get 20 episodes a month with CME/MOC credit at www.acc.org/ACCEL.
Released:
Sep 21, 2021
Format:
Podcast episode
Titles in the series (100)
ACCEL Lite: STRENGTH Trial: High-Dose Omega-3 Fatty Acids vs. Corn Oil: The benefits and risks of fish oil derivatives remain controversial. STRENGTH (Long-Term Outcomes Study to Assess Statin Residual Risk With Epanova in High Cardiovascular Risk Patients With Hypertriglyceridemia) showed no benefits from administration... by ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research